Medical/Pharmaceuticals

George Clinical Applauded by Frost & Sullivan for Improving Clinical Trial Efficiency and Patient-centricity through Impactful, Strategic Partnerships

Innovation through impactful, strategic partnerships improves efficiency and delivers scientific leadership and patient-centricity in clinical trials execution. SANTA CLARA, Calif., Nov. 30, 2021 /PRNewswire/ -- Based on its recent analysis of theAsia-Pacific clinical contract research organizat...

2021-11-30 20:33 1414

Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of TTK inhibitor, CFI-402257

NEW YORK and HONG KONG, Nov. 30, 2021 /PRNewswire/ -- Treadwell Therapeutics, a clinical stage biotechnology company developing novel therapeutics for highly aggressive cancers, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) applic...

2021-11-30 20:00 2256

Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant

SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530),  South Korea's leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is capable of detecting the Omicron's unique pattern of mutations. The well-established PCR-based test recogni...

2021-11-30 19:25 2149

JOYSBIO's SARS-COV-2 Antigen Rapid test detects OMICRON variant

TIANJIN, China, Nov. 30, 2021 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is proud to announce that their tests are available around the world. Furthermore, they've been able to show that their test can detect the new Omicron (B.1.1.529). This va...

2021-11-30 14:00 1951

Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS® Oral Contraceptive

ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce the Therapeutic Goods Administration (TGA) has approved the novel combined oral contraceptive NEXTSTELLIS® (14.2 mg of es...

2021-11-30 09:18 2354

Sciwind Biosciences Acquires Global, Exclusive Rights to Develop and Commercialize Sanofi's GIP Receptor Agonists for the Treatment of Metabolic Disease

HANGZHOU, China and SAN FRANCISCO, Nov. 30, 2021 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced today that it has signed a global, exclusive license agreemen...

2021-11-30 08:00 2780

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicine Symposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma...

2021-11-30 03:35 2104

Hummingbird Bioscience Appoints Jan Møller Mikkelsen as Chairman of the Board

HOUSTON and SINGAPORE, Nov. 29, 2021 /PRNewswire/ -- Hummingbird Bioscience Holdings Limited, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, today announced the appointment of Jan Møller Mikkels...

2021-11-29 17:00 1762

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market

SHANGHAI and SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the development and commercialization of innovative targeted radiopharmaceutical therapies (TRT) against tumor targets, announced a$75 million Series A finan...

2021-11-29 10:00 3440

VISTA Eye Specialist Shares How It Thrives during the COVID-19 Pandemic

PETALING JAYA, Malaysia, Nov. 29, 2021 /PRNewswire/ -- As part of VISTA Eye Specialists' (VISTA) core value of 'Giving Back to the Community', VISTA does not only give for charity, but believes strongly in sharing of knowledge and experiences. Other than sharing via conferences and publications, ...

2021-11-29 09:40 2168

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research

TAIPEI, Nov. 27, 2021 /PRNewswire/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof.Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) onNovember 26, the 2020 Tang Prize...

2021-11-27 16:00 4637

ASUS and Medical Professionals Showcase Five Smart Healthcare Achievements

SINGAPORE, Nov. 26, 2021 /PRNewswire/ -- ASUS Intelligent Cloud Services (AICS) today introduced five smart medical solutions during its AICS Medical Open House. The xHIS platform, the Lumos EMR search platform, the Drug Safety Service, the Miraico smart medical coding assistant and the Personal ...

2021-11-26 21:47 5208

Australian biotech company Starpharma announces positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had efficacy responses, utilising one or more standard measures of disease. DEP® cabazitaxel  is a patent...

2021-11-26 17:34 2721

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse

REYKJAVÍK, Iceland, Nov. 26, 2021 /PRNewswire/ -- Aztiq   ("Aztiq"), a healthcare investor led by Alvogen Founder and Chairman Róbert Wessman, andInnobic (Asia) Company Limited ("Innobic"), a life sciences subsi...

2021-11-26 15:51 2465

Starpharma releases positive DEP® phase 2 interim results in prostate cancer

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel. The company showed that 100% of evaluable patients with (Stage IV) metastatic prostat...

2021-11-26 15:41 2048

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Red Ginseng One of the best ginseng in the world, Korean ginseng became a premi...

2021-11-26 15:37 2823

Premium Red Ginseng Brand CheongKwanJang to Celebrate 122nd anniversary

SEOUL, South Korea, Nov. 26, 2021 /PRNewswire/ -- Korea Ginseng Corp (KGC) celebrates the 122nd anniversary of its premium red ginseng brand, CheongKwanJang. Korean Ginseng One of the best ginseng in the world, Korean ginseng became a...

2021-11-26 15:28 3137

Antengene Included in the MSCI Global Small Cap Indexes - MSCI China Index Constituent Stocks

SHANGHAI and HONG KONG, Nov. 26, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...

2021-11-26 11:34 3681

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, andAsia-based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Heal...

2021-11-25 22:00 3149

How CIIE offers a window for multinational companies into the Chinese market

SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- Opening up is the hallmark of contemporaryChina. The China International Import Expo (CIIE) is poised to shape a link betweenChina and the global market.   Scheduled from Nov 5 to 10, the 4th CIIE presented a total of 422 new products, technologies, and s...

2021-11-25 18:37 3039
1 ... 192193194195196197198 ... 382